milk thistle extract (silymarin)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
milk thistle extract (silymarin) — decreases alanine aminotransferase
Evidence strength: very limited.Finding“Silymarin monotherapy versus no intervention or placebo may decrease ALT (MD -7.21 U/L, 95% CI -10.62 to -3.80; 6 trials, 409 participants; very low-certainty evidence) and GGT (MD -8.30 U/L, 95% CI -12.43 to -4.17; 1 trial, 45 participants; very low-certainty evidence), but the evidence is very uncertain.”
Quoted verbatim from Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.. - Study
- meta-analysis
- Participants
- 409
- Population
- Adults with metabolic dysfunction-associated steatotic liver disease; silymarin monotherapy versus no intervention or placebo, maximal follow-up
Effect -7.21 mean difference, 95% CI -10.62 to -3.8
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.2025PMID:4055256910.1002/14651858.CD015524.pub2Permalink
To cite this finding: https://catalystproject.ai/e/01M5SS6TF4Y8H28E1S04NYK9MF